Sanofi SA (SNY)

40.21
0.14 0.35
NYSE : Health Care
Prev Close 40.35
Open 40.34
Day Low/High 39.91 / 40.35
52 Wk Low/High 36.81 / 44.50
Volume 2.10M
Avg Volume 2.22M
Exchange NYSE
Shares Outstanding 2.57B
Market Cap 103.41B
EPS 1.90
P/E Ratio 21.60
Div & Yield 1.66 (4.10%)

Latest News

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.

4 Biotech Names That Could Be M&A Targets

4 Biotech Names That Could Be M&A Targets

Animal health and oncology deal activity is heating up in 2017.

5 Rocket Stocks for 2017 -- Amgen, eBay, More

5 Rocket Stocks for 2017 -- Amgen, eBay, More

These stocks are showing short-term gain catalysts and longer-term growth potential. Here's how to trade them.

Here's Why Teva Shares Are Plummeting

Here's Why Teva Shares Are Plummeting

Shares fall on worse-than-expected guidance. It was not a good day for Teva Pharmaceuticals.

Jim Cramer Sees Buying Opportunities in Praluent Patent Suit

Jim Cramer Sees Buying Opportunities in Praluent Patent Suit

After a court halts Regeneron's sales of Praluent, Jim Cramer sees opportunity in Amgen.

Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View

Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View

The Medicines Company, Alder also see share boosts on favorable implications. Jim Cramer weighs in on the implications for Amgen investors.

Regeneron Cholesterol-Lowering Drug Banned From U.S. Market

Regeneron Cholesterol-Lowering Drug Banned From U.S. Market

A federal judge has banned the sale of Regeneron's cholesterol-lowering drug Praluent, handing a surprise and overwhelming victory to Amgen and its competing drug Repatha in a long-running patent lawsuit.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

U.S. stock futures trade slightly lower Friday ahead of the U.S. jobs report for December, the last under the Obama presidency.

Sanofi Investors Have Worst Day in Six Months

Sanofi Investors Have Worst Day in Six Months

Praluent Infringes on Amgen's patents for rival drug, Repatha, a ruling says.

After Stunning Loss to Amgen in Patent Case, Regeneron Plans to Join Sanofi in Appeal

After Stunning Loss to Amgen in Patent Case, Regeneron Plans to Join Sanofi in Appeal

A federal judge has banned the sale of Regeneron's cholesterol-lowering drug Praluent, handing a surprise and overwhelming victory to Amgen and its competing drug Repatha in a long-running patent lawsuit.

European Stocks Open Lower as Investors Prep for U.S. Jobs Report

European Stocks Open Lower as Investors Prep for U.S. Jobs Report

European shares open with a defensive tone ahead of U.S. December nonfarm payrolls; Sanofi slumps on the Praluent injunction.

(Graphic: Business Wire)

(Graphic: Business Wire)

Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi's animal health business (Merial) and Boehringer Ingelheim's consumer...

Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm

Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm

Actelion's CEO has held control at the company he founded, but its largest shareholder has ties with Johnson & Johnson.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures post slight losses as investors await data on U.S. growth and durable goods; Carl Icahn is named special adviser to President-elect Donald Trump on overhauling federal regulations.

Actelion Hits Record High After Confirming Exclusive Talks With Johnson & Johnson

Actelion Hits Record High After Confirming Exclusive Talks With Johnson & Johnson

Shares in the biotech firm hit a record high Thursday after confirming 'exclusive' talks with Johnson & Johnson.

European Stocks Drift Lower in Holiday-Thinned Trading

European Stocks Drift Lower in Holiday-Thinned Trading

European stocks are likely to post modest losses Thursday as a slower holiday trading pace takes over regional markets.

Dow's Ascent to 20,000 Milestone Hits Snag

Dow's Ascent to 20,000 Milestone Hits Snag

The Dow Jones Industrial Average's steady path to its 20,000 milestone hit the pause button on Wednesday after a meandering day of slight losses.

Stocks Sport Slight Losses as Dow's Journey to 20,000 Pauses

Stocks Sport Slight Losses as Dow's Journey to 20,000 Pauses

Stocks hold slightly lower on Wednesday as the Dow Jones Industrial Average hovers around 40 points below its 20,000 milestone.

Actelion Restarts Possible Merger Talks With Johnson & Johnson

Actelion Restarts Possible Merger Talks With Johnson & Johnson

The Swiss biotech says it's in exclusive talks with J&J about a possible 'strategic transaction.'

Actelion Shares Rise Amid Speculation on Possible Improved Sanofi Bid

Actelion Shares Rise Amid Speculation on Possible Improved Sanofi Bid

Shares in the Swiss biotech surge amid reports that Sanofi could use a 'CVR' technique to enhance the potential bid price.

Analysts Mixed on Health Care Stocks in the New Year

Analysts Mixed on Health Care Stocks in the New Year

While there is deep uncertainty about how politics will affect the health care sector in the new year, analysts seem excited about some opportunities in pharmaceuticals.

Innate Pharma Pops as It Names AstraZeneca's Oncology Head as Chairman

Innate Pharma Pops as It Names AstraZeneca's Oncology Head as Chairman

Meanwhile, Astrazeneca's shares fall as its head of oncology leaves for the smaller biotech company.

Disney Stock Upgraded on Force of 'Rogue One's' Huge Opening Weekend

Disney Stock Upgraded on Force of 'Rogue One's' Huge Opening Weekend

The success of its first Star Wars spin-off and other 'blockbuster-level' film releases make Disney a stock to own, according to Bank of America.

The Best Biopharma CEOs of 2016 Are...

The Best Biopharma CEOs of 2016 Are...

The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.

Dow on Track for Sixth Straight Week of Gains Even as Markets Fall

Dow on Track for Sixth Straight Week of Gains Even as Markets Fall

The Dow Jones Industrial Average held slight weekly gains on Friday afternoon even in a down day for Wall Street.

Dow Eyes 20,000 as Stocks Drift Higher

Dow Eyes 20,000 as Stocks Drift Higher

Stocks rise on Friday, putting the Dow Jones Industrial Average one step closer to the psychologically important 20,000 level.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

U.S. stock futures are mixed while the dollar surges as global markets adjust to higher U.S. interest rates; Facebook plans to fact-check its news; Adobe's earnings top forecasts.